Type of Study:
Type 1 diabetes patients who are 18 – 40 years
18 – 40 years, Male and Female
Participants will receive at no cost: study product, study materials and study-specific procedures
The SUNRISE study is a prospective, multi-center, double-blind, randomized, placebo-controlled trial in subjects aged 18.0 to <41.0 years diagnosed with T1D within 5 years.